Beijing Winsunny Pharmaceutical CO.LTD (601089) — Free Cash Flow Generation Index

Latest as of December 2024: 0.43x

Beijing Winsunny Pharmaceutical CO.LTD (601089) has a Free Cash Flow Generation Index of 0.43x as of December 2024. Free cash flow of CN¥299.23 Million represents 0% of operating cash flow (CN¥690.75 Million). See Beijing Winsunny Pharmaceutical CO.LTD current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.43x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥299.23 Million
CNY

Operating Cash Flow

CN¥690.75 Million
CNY

Capital Expenditures

CN¥391.52 Million
CNY

Beijing Winsunny Pharmaceutical CO.LTD Free Cash Flow Generation Index (2020–2024)

Historical FCF Generation Index trend for Beijing Winsunny Pharmaceutical CO.LTD across 5 annual periods. Explore how well can Beijing Winsunny Pharmaceutical CO.LTD service its debt to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Beijing Winsunny Pharmaceutical CO.LTD (2020–2024)

Year-by-year Free Cash Flow Generation Index for Beijing Winsunny Pharmaceutical CO.LTD. For the full company profile including market capitalisation, see 601089 market cap overview.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2024 0.43x CN¥299.23 Million CN¥690.75 Million CN¥391.52 Million ▲ +26.9%
2023 0.34x CN¥189.82 Million CN¥555.90 Million CN¥366.08 Million ▼ -57.0%
2022 0.79x CN¥524.36 Million CN¥659.76 Million CN¥135.40 Million ▲ +25.3%
2021 0.63x CN¥335.05 Million CN¥528.02 Million CN¥192.97 Million ▲ +12.7%
2020 0.56x CN¥217.69 Million CN¥386.65 Million CN¥168.96 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).